News › Pharmaceuticals  ·  12 May 2026, 8:34 AM IST  ·  4 months ago

Bullish Signal: Motilal Oswal Recommends SUNPHARMA, FORTIS, GRASIM

VolatileBias: Bullish +6990% confidencePharmaceuticalsHealthcareBullish read

In one line — Given the positive analyst sentiment and recent market correction, a 'watch on dips' strategy for quality pharma stocks like SUNPHARMA could be effective, with a bullish bias.

Bearish
Bullish
−1000+69+100

Source: Mint · AI-summarised by Anadi · Updated 12 May 2026, 9:00 AM IST

Pharmaceuticalstilt positive
Healthcaretilt positive
Diversifiedtilt positive

What Happened

Chandan Taparia from Motilal Oswal has issued 'buy' recommendations for Sun Pharmaceutical Industries, Fortis Healthcare, and Grasim Industries for May 12, 2026. This provides specific actionable advice to traders looking for entry points in the current market.

Why It Matters (for you)

Such recommendations from a reputable analyst like Chandan Taparia often lead to increased trading activity and potential price appreciation in the short term for the mentioned stocks. It offers a directional cue for investors, especially after a day of significant market correction.

Impact on Indian Markets

SUNPHARMA, FORTIS, and GRASIM are likely to see positive sentiment and increased buying interest at market open. This could lead to an upward price movement, potentially outperforming the broader market, especially if the overall market sentiment improves after yesterday's crash.

What Traders Should Watch Next

Traders should monitor the opening prices and volumes of these three stocks. Look for confirmation of buying interest and consider the broader market's reaction to yesterday's fall. Setting appropriate risk control is crucial given the recent volatility.

Key Evidence

  • Chandan Taparia of Motilal Oswal recommended three stocks to buy today, May 12, 2026.
  • The recommended stocks are Sun Pharmaceutical Industries, Fortis Healthcare, and Grasim Industries.
  • The Nifty50 recently closed above 24,350, while the Sensex experienced a significant crash yesterday (May 11, 2026), falling over 1,312 points.
  • Risk flag: Potential for broader market weakness to override stock-specific recommendations.
  • Risk flag: Regulatory changes or USFDA actions could impact pharma stocks.